Paramedic Papers

Home Toxicology Prehospital olanzapine for meth toxicity

Toxicology

Prehospital olanzapine for meth toxicity

Impact of prehospital olanzapine for methamphetamine intoxication on patient and system-level outcomes: a population-based retrospective cohort study
BMJ Open · Added 13 October 2026

Population-based Winnipeg cohort evaluating a 2018 policy letting paramedics give olanzapine for methamphetamine intoxication — treated patients were far more likely to be transported to ED (aOR 11.83) and seen by a doctor, and less likely to leave before being seen (aOR 0.56).

Study type
Cohort
Design
Retrospective pre-post population-based cohort (inverse probability of treatment weighting)
Participants
1,041 individuals with methamphetamine-related contacts, 222 given prehospital olanzapine
Main finding
Olanzapine recipients more likely to be transported to ED (aOR 11.83, 95% CI 3.19–43.80) and less likely to leave ED without being seen (aOR 0.56, 95% CI 0.32–0.97)
Caveat
Retrospective pre-post design with confounding by indication — the sickest patients were presumably the ones treated
Bottom line
Hypothesis-generating

Why it matters in Australia (High relevance). Olanzapine for agitation is carried by all seven Australian ambulance services and methamphetamine presentations are a daily reality, so the system-level findings translate directly.

Learning goal

Weigh the benefits and risks of prehospital olanzapine for methamphetamine intoxication and its impact on transport decisions.

Open in dashboard Read the paper (DOI)

More

Related papers on Toxicology